Additional File 14 of the Novel Transcriptomic Signature of Angiogenesis Predicts Clinical Outcome, Tumor Microenvironment and Treatment Response for Prostate Adenocarcinoma

Chengyuan Gu,Bo Dai,Yan Zhu,Guo‐Wen Lin,Hongkai Wang,Ding-Wei Ye,Xiaojian Qin

DOI: https://doi.org/10.6084/m9.figshare.20315831

2022-01-01

Abstract:Additional file 14. Table S8. The Hallmark gene set enrichment analysis underlying the ARGs signature.

What problem does this paper attempt to address?

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Cheng-Yuan Gu,Bo Dai,Yao Zhu,Guo-Wen Lin,Hong-Kai Wang,Ding-Wei Ye,Xiao-Jian Qin

DOI: https://doi.org/10.1186/s10020-022-00504-6

2022-07-16

Molecular Medicine

Abstract:Angiogenesis plays the critical roles in promoting tumor progression, aggressiveness, and metastasis. Although few studies have revealed some angiogenesis-related genes (ARGs) could serve as prognosis-related ...

biochemistry & molecular biology,cell biology,medicine, research & experimental
Additional File 3: Table S5. of Differential Expression Analysis at the Individual Level Reveals a Lncrna Prognostic Signature for Lung Adenocarcinoma

Fuduan Peng,Ruiping Wang,Yuanyuan Zhang,Zhangxiang Zhao,Wenbin Zhou,Zhiqiang Chang,Haihai Liang,Wenyuan Zhao,Lishuang Qi,Zheng Guo,Yunyan Gu

DOI: https://doi.org/10.6084/m9.figshare.c.3796993_d3

2017-01-01

Abstract:Detail information of differentially expressed lncRNAs identified based on microarray data. (XLSX 275 kb)
Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Yujie Shen,Qiang Huang,Yifan Zhang,Chi‐Yao Hsueh,Liang Zhou

DOI: https://doi.org/10.6084/m9.figshare.20279354

2022-01-01

Abstract:Additional file 11: Table S5. Enrichment analysis of sub-networks.
A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer

Weiyu Ge,Daiyuan Shentu,Yongchao Wang,Yanling Wang,Shengbai Xue,Ming Yue,Tiebo Mao,Xiaofei Zhang,Haiyan Xu,Shumin Li,Jingyu Ma,Jiayu Yao,Jiujie Cui,Liwei Wang

DOI: https://doi.org/10.3389/fcell.2022.1001606

IF: 5.5

2022-10-07

Frontiers in Cell and Developmental Biology

Abstract:Angiogenesis, a hallmark of cancer, is related to prognosis, tumor progression, and treatment response. Nevertheless, the correlation of angiogenesis-based molecular signature with clinical outcome and immune cell infiltration has not been thoroughly studied in pancreatic cancer. In this study, multiple bioinformatics methods were combined to evaluate prognosis, immune cell infiltration, and the alterations of angiogenesis-related genes (ARGs) in PC samples, and further establish a novel angiogenesis-related gene signature. Moreover, the protein and mRNA expression levels of four angiogenesis risk genes were determined by Human Protein Atlas (HPA) database and qPCR analysis, respectively. Here, we recognized two distinct angiogenesis subtypes and two gene subtypes, and revealed the critical roles of ARGs in the tumor immune microenvironment (TIME), clinical features, and prognosis. Consequently, we established an ARGs score to predict prognosis and therapeutic response of PC patients, and validated its robust predictive ability. Additionally, the ARGs score was markedly associated with clinical outcomes, tumor mutation burden (TMB), and chemotherapeutic drug sensitivity. In brief, our findings imply that the ARGs score is a robust prognostic indicator and may contribute to the development of effective individualized therapies for PC.

cell biology,developmental biology
A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

Huan Wang,Yueli Shi,Xia Xu,Shumin Xu,Yuting Shi,Weiyu Chen,Kai Wang

DOI: https://doi.org/10.1080/07853890.2023.2279754

2023-01-01

Abstract:Background Neutrophil extracellular traps (NETs) could entrap tumour cells and promote their dissemination and metastasis. Further analysis of NETs-related molecules is expected to provide a new strategy for prognosis prediction and treatment of lung adenocarcinoma (LUAD) patients.Methods The model construction was established through co-expression analysis, Lasso Cox regression, univariate and multivariate COX regression, Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway. The potential drugs and analysed drug sensitivity were screened by pRRophetic packages.Results In this study, we constructed a 15 NETs-related long non-coding RNAs (lncRNAs) prognostic prediction model (AC091057.1, SPART-AS1, AC023796.2, AL031600.2, AC084781.1, AC032011.1, FAM66C, C026355.2, AL096870.2, AC092718.5, PELATON, AC008635.1, AL162632.3, AC087501.4 and AC123768.3) for patients with early-stage LUAD based on public databases and datasets. The signature is associated with immune cell functions, tumour mutation burden and treatment sensitivity in LUAD patients. Additionally, we found that FAM66C is highly expressed in lung cancer patients for the first time, which is associated with poor prognosis. FAM66C knockdown significantly inhibited the proliferation and migration ability of the tumour cells.Conclusions In conclusion, this model is a new and effective prognostic and efficacy predictive biomarker, FAM66C plays an oncogene role in the process of LUAD development. It may provide a new theoretical basis for the clinical diagnosis and treatment in LUAD patients in early stage.
Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma

Tianhao Hu,Yutao Wang,Xiaoliang Wang,Run Wang,Yifu Song,Li Zhang,Sheng Han

DOI: https://doi.org/10.3389/fgene.2022.934683

IF: 3.7

2022-08-11

Frontiers in Genetics

Abstract:Background: Glioma is the most prevalent malignant intracranial tumor. Many studies have shown that angiogenesis plays a crucial role in glioma tumorigenesis, metastasis, and prognosis. In this study, we conducted a comprehensive analysis of angiogenesis-related genes (ARGs) in glioma. Methods: RNA-sequencing data of glioma patients were obtained from TCGA and CGGA databases. V ia consensus clustering analysis, ARGs in the sequencing data were distinctly classified into two subgroups. We performed univariate Cox regression analysis to determine prognostic differentially expressed ARGs and least absolute shrinkage and selection operator Cox regression to construct a 14-ARG risk signature. The CIBERSORT algorithm was used to explore immune cell infiltration, and the ESTIMATE algorithm was applied to calculate immune and stromal scores. Results: We found that the 14-ARG signature reflected the infiltration characteristics of different immune cells in the tumor immune microenvironment. Additionally, total tumor mutational burden increased significantly in the high-risk group. We combined the 14-ARG signature with patient clinicopathological data to construct a nomogram for predicting 1-, 3-, and 5-year overall survival with good accuracy. The predictive value of the prognostic model was verified in the CGGA cohort. SPP1 was a potential biomarker of glioma risk and was involved in the proliferation, invasion, and angiogenesis of glioma cells. Conclusion: In conclusion, we established and validated a novel ARG risk signature that independently predicted the clinical outcomes of glioma patients and was associated with the tumor immune microenvironment.

genetics & heredity
Additional File 4 of Multi-omics Analysis of Tumor Angiogenesis Characteristics and Potential Epigenetic Regulation Mechanisms in Renal Clear Cell Carcinoma

Wenzhong Zheng,Shiqiang Zhang,Huimin Guo,Xiaobao Chen,Zhangcheng Huang,Shaoqin Jiang,Mengqiang Li

DOI: https://doi.org/10.6084/m9.figshare.14299615

2021-01-01

Abstract:Additional file 4: Table S1. Ten independent angiogenesis reference gene sets.
Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients

Hao Li,Lu Chen,Zhi-Bin Ke,Shao-Hao Chen,Xue-Yi Xue,Qing-Shui Zheng,Yong Wei,Kai Zeng,Ning Xu

DOI: https://doi.org/10.2147/IJGM.S332732

IF: 2.145

2021-01-01

International Journal of General Medicine

Abstract:Background: This study aimed to develop and validate a novel angiogenesis-related gene (ARG) signature and molecular subtypes by bioinformatics analysis. Materials and Methods: The transcriptome data and clinical data were obtained from TCGA and ICGC database. We performed consensus clustering analysis to identify angiogenesis molecular subtypes for ccRCC. Univariate and multivariate Cox regression analyses were used to develop a novel ARG-related signature as a prognostic biomarker for ccRCC. Internal and external validation were then performed in TCGA and ICGC cohort, respectively. Results: We identified a total of two angiogenesis molecular subtypes of ccRCC. The overall survival (OS) of subtype 1 ccRCC was significantly decreased compared with that of subtype 2 ccRCC (P=0.001). These two molecular subtypes have significantly different tumor microenvironment and immune checkpoint inhibitor sensitivities (P<0.05). Besides, we developed a novel signature based on three ARGs (including MSX1, TIMP1 and JAG2) for subtype 1 ccRCC. The difference in OS between high-and low-risk group was statistically significant in training cohort (P=0.009), test cohort (P=0.024), the whole type 1 cohort (P<0.001), and validation cohort (P=0.041). The AUC for one-year OS prediction was 0.732, 0.710, 0.725, and 0.645 in training cohort, test cohort, the whole type 1 cohort, and validation cohort, respectively. Independent prognostic analysis showed that this signature was an independent predictor for OS of subtype 1 ccRCC (P=0.028914). The power of this prognostic signature was superior to other signatures reported in previous studies. Conclusion: We developed and successfully validated a novel ARG signature for predicting prognosis of subtype 1 ccRCC, which was superior to several previous signatures.
Additional File 1 of Identification of a Tumor Microenvironment-Related Seven-Gene Signature for Predicting Prognosis in Bladder Cancer

Zhi Wang,Lei Tu,Minfeng Chen,Seo Yun Tong

DOI: https://doi.org/10.6084/m9.figshare.14767230

2021-01-01

Abstract:Additional file 1: Table S1. GO analysis of 4 TME-related co-expression modules (magenta, brown, purple and yellow).
Additional File 5 of A Novel Signature of Two Long Non-Coding RNAs in BRCA Mutant Ovarian Cancer to Predict Prognosis and Efficiency of Chemotherapy

Yinglian Pan,Jia Li,Yuzhu Liu,Yiyu Han,Qian Li,Qin Zou,Zhongpei Zhang,Jin Long Huang,Qingchun Deng

DOI: https://doi.org/10.6084/m9.figshare.12980286

2020-01-01

Abstract:Additional file 5: Table S4. Functional enrichment analysis of different mRNAs.
Bioinformatics Evaluation of a Novel Angiogenesis Related Genes-Based Signature for Predicting Prognosis and Therapeutic Efficacy in Patients with Gastric Cancer.

Ning Ma,Jie Li,Ling Lv,Chunhua Li,Kainan Li,Bin Wang

2022-01-01

Abstract:OBJECTIVE:Tumor angiogenesis plays a pivotal role in the development and metastasis of tumors. This study aimed to elucidate the association between angiogenesis-related genes (ARGs) and the prognosis of patients with gastric cancer (GC).METHODS:Transcriptomics and clinical data of GC samples were obtained from The Cancer Genome Atlas (TCGA) as the training group and those from Gene Expression Omnibus (GEO, including GSE26253, GSE26091 and GSE66229) as the validation groups. Single-sample gene set enrichment analysis (ssGSEA) was performed for gene set enrichment analysis on the gene set of angiogenesis and divided patients into high- or low-ARG group. Subsequently, to improve the availability of the ARG signature, a ARGs subtype predictor was then constructed by integrating of four machine learning methods, including support vector machine (SVM), least absolute shrinkage and selection operator (LASSO) regression, Random Forest and Boruta (RFB) and extreme gradient boosting (XGBoost). Kaplan-Meier and receiver operating characteristic curves were used to evaluate the performance of prognosis prediction. The EPIC and xCELL method were used to calculate the profile of tumor-infiltrated immune cells.RESULTS:The expression levels of a total of 36 ARGs that correlated with the survival of patients with GC were identified and utilized to establish an ARG-related prognosis signature. The area under the curve for predicting overall survival (OS) in the training group at the 1-, 3- and 5-year was 0.61, 0.64 and 0.76, respectively, and this was further validated using three independent GEO datasets. Moreover, the ARG signatures were significantly correlated with cancer-associated fibroblasts (CAFs), and GC patients that exhibited both high ARG expression level and matrix CAFs level had the most inferior outcomes. The multiple machine learning algorithms were applied to establish a 10-gene ARG subtype predictor, and notably, a high ARG-subtype predictor score was associated with reduced efficacy of immunotherapy, and potential anti-HER2 or FGFR4 therapy, but an increased sensitivity to anti-angiogenesis-related therapy.CONCLUSION:The novel ARGs-based classification may act as a potential prognostic predictor for GC and be used as a guidance for clinicians in selecting potential responders for immunotherapy and targeted therapy.
Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma

Guoliang Cui,Jinhui Liu,Manli Wang,Kinyu Shon,Can Wang,Fei Wei,Zhiguang Sun

DOI: https://doi.org/10.3389/fimmu.2022.1049485

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:BackgroundColorectal adenocarcinoma (COAD) is one of the most common malignancies and angiogenesis is vital to the development of cancer. Here, we explored the roles of angiogenesis-related genes (ARGs) that affect the prognosis of COAD and constructed risk models to assess patient prognosis, immune characteristics, and treatment outcomes. MethodsWe comprehensively characterized the transcriptional and genetic modifications of 48 ARGs in COAD and evaluated the expression patterns. We identified two ARG subgroups using the consensus clustering algorithm. Based on the differentially expressed genes (DEGs) of two ARG subtypes, we calculated risk score, namely ARG_scores, and calssified COAD patients into different risk groups. To investigate the expression of ARG_score-related genes, qRT-PCR was performed. Subsequently, we mapped the nomogram to visually and accurately describe the value of the application of ARG_score. Finally, the correlation between ARG_score and clinical features, immune infiltration along with drug sensitivity were explored. ResultsWe identified two ARG related subgroups and there were great differences in overall survival (OS) and tumor microenvironment. Then, we created an ARG_score for predicting overall survival based on eight DEGs and confirmed its reliable predictive power in COAD patients, with higher ARG_score associated with worse prognosis. Furthermore, eight ARG_score-related genes expression was investigated by qRT-PCR. To make the ARG_score clinically feasible, we created a highly reliable nomogram. We also found a higher proportion of microsatellite instability-high (MSI-H) and higher tumor mutational burden (TMB) in the high-risk group. In addition, ARG_score was notably correlated with cancer stem cell indices and drug sensitivity. ConclusionThis scoring model has potential clinical application value in the prognosis, immune microenvironment and therapeutic drug sensitivity of COAD, which provides new insights for personalized treatment.
Supplementary Figure 6 from Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Ruiliang Wang,Qiufan Xu,Hanxu Guo,Guanjie Yang,Jun Zhang,Hong Wang,Tianyuan Xu,Changcheng Guo,Jing Yuan,Yanyan He,Xiaoying Zhang,Hongliang Fu,Guang Xu,Binghui Zhao,Jun Xie,Tingting Zhao,Longfei Huang,Jiansheng Zhang,Bo Peng,Xudong Yao,Bin Yang

DOI: https://doi.org/10.1158/2767-9764.24496172

2023-01-01

Abstract:Ability of alterations affecting signaling pathways in progressive tumor tissue or matched ctDNA to predict OS of patients with AVPC.
Additional File 1 of Wnt Pathway-Related Three-Mrna Clinical Outcome Signature in Bladder Urothelial Carcinoma: Computational Biology and Experimental Analyses

Shengrong Sun,Yutao Wang,Jianfeng Wang,Jianbin Bi

DOI: https://doi.org/10.6084/m9.figshare.16689587

2021-01-01

Abstract:Additional file 1. Table S1. The list of WNT pathway genes name in KEGG.
Analysis of Angiogenesis-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Lung Adenocarcinoma.

Qing Zhou,Xi Chen,Qiuyan Chen,Lu Hao

DOI: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2023047785

2023-01-01

Critical Reviews in Eukaryotic Gene Expression

Abstract:Tumor angiogenesis is considered to be an important part of the mechanism of tumor progression and metastasis, and its specific function in lung adenocarcinoma has not been fully studied. In this study, we used the transcriptome and genome data of lung adenocarcinoma patients to analyze the expression of 36 angiogenesis regulators in lung adenocarcinoma. Consensus clustering analysis divided lung adenocarcinoma samples into 4 subtypes, A, B, C, and D, and the expression of most angiogenesis regulators in subtype B was higher than that in other subtypes. Immunological analysis indicated that subtype B is likely to display the characteristics of a hot tumor with a more active TME. With the help of Lasso-Cox regression analysis, we successfully constructed a risk model involving five Angiogenesis Regulators genes (CCND2, JAG1, MSX1, STC1, TIMP1), which will be helpful for clinical personalized treatment and prognosis prediction. In addition, JAG1 has the highest mutation rate in tumors, and its cancer-promoting function is reflected in a variety of tumors, which provides important clues for the development of new broad-spectrum anti-cancer targets in the future. We successfully constructed a risk model involving five angiogenesis regulators genes (CCND2, JAG1, MSX1, STC1, TIMP1), which may be helpful for clinical personalized treatment and prognosis prediction. In addition, JAG1 has the highest mutation rate in tumors and plays a leading role in the protein interaction network. Its tumor-promoting function is reflected in a variety of tumors and may become a broad-spectrum anti-cancer target in the future.
Identification of angiogenesis‐related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer

Feifei Wang,Changjing Wang,Baokun Li,Guanglin Wang,Zesong Meng,Jiachao Han,Ganlin Guo,Bin Yu,Guiying Wang

DOI: https://doi.org/10.1002/bab.2520

2023-10-27

Biotechnology and Applied Biochemistry

Abstract:Angiogenesis is associated with tumor progression, prognosis, and treatment effect. However, the angiogenesis' underlying mechanisms in the tumor microenvironment (TME) still remain unclear. Understanding the dynamic interactions between angiogenesis and TME in colon adenocarcinoma (COAD) is necessary. We downloaded the transcriptome data and corresponding clinical data of colon cancer patients from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases, respectively. We identified two distinct angiogenesis‐related molecular subtypes (subtype A and subtype B) and assessed the clinical features, prognosis, and infiltrating immune cells of patients in the two subtypes. According to the prognostic differential genes, we defined two different gene clusters to further explore the correlation between angiogenesis and tumor heterogeneity. Then, we construct the prognostic risk scoring model angiogenesis‐related gene (ARG‐score) including seven genes (ARMCX2, latent transforming growth factor β binding protein 1, ADAM8, FABP4, CCL11, CXCL11, ITLN1) using Lasso‐multivariate cox method. We analyzed the correlation between ARG‐score and prognosis, clinicopathological features, TME, molecular feature, cancer stem cells (CSCs), and microsatellite instability (MSI) status. To assess the application value of ARG‐score in clinical treatment, immunophenotype score was used to predict patients' immunotherapy response in colon cancer. We found the mutations of ARGs in TCGA–COAD dataset from genetic levels and discussed their expression patterns based on TCGA and GEO datasets. We observed important differences in clinicopathological features, prognosis, immune feature, molecular feature between the two molecular subgroups. Then, we established an ARG‐score for predicting OS and validated its predictive capability. A high ARG‐score characterized by higher transcription level of ARGs, suggested lower MSI‐high (MSI‐H), lower immune score, and worse clinical stage and survival outcome. Additionally, the ARG‐score was remarkably related to the CSCs index and immunotherapy sensitivity. We found two new molecular subtypes and two gene clusters based on ARGs and established an ARG‐score. Multilayered analysis revealed that ARGs were remarkably correlated to the heterogeneity of colon cancer patients and explained the process of tumorigenesis and progression better. The ARG‐score can help us better assess patients' survival outcomes and provide guidance for individualized treatment.

biotechnology & applied microbiology,biochemistry & molecular biology
Integrative Profiling Analysis Reveals Prognostic Significance, Molecular Characteristics, and Tumor Immunity of Angiogenesis-Related Genes in Soft Tissue Sarcoma

Binfeng Liu,Chenbei Li,Chengyao Feng,Hua Wang,Haixia Zhang,Chao Tu,Shasha He,Zhihong Li

DOI: https://doi.org/10.3389/fimmu.2023.1178436

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:BackgroundSoft tissue sarcoma (STS) is a class of malignant tumors originating from mesenchymal stroma with a poor prognosis. Accumulating evidence has proved that angiogenesis is an essential hallmark of tumors. Nevertheless, there is a paucity of comprehensive research exploring the association of angiogenesis-related genes (ARGs) with STS.MethodsThe ARGs were extracted from previous literature, and the differentially expressed ARGs were screened for subsequent analysis. Next, the least absolute shrinkage and selection operator (LASSO) and Cox regression analyses were conducted to establish the angiogenesis-related signature (ARSig). The predictive performance of the novel ARSig was confirmed using internal and external validation, subgroup survival, and independent analysis. Additionally, the association of the ARSig with the tumor immune microenvironment, tumor mutational burden (TMB), and therapeutic response in STS were further investigated. Notably, we finally conducted in vitro experiments to verify the findings from the bioinformatics analysis.ResultsA novel ARSig is successfully constructed and validated. The STS with a lower ARSig risk score in the training cohort has an improved prognosis. Also, consistent results were observed in the internal and external cohorts. The receiver operating characteristic (ROC) curve, subgroup survival, and independent analysis further indicate that the novel ARSig is a promising independent prognostic predictor for STS. Furthermore, it is proved that the novel ARSig is relevant to the immune landscape, TMB, immunotherapy, and chemotherapy sensitivity in STS. Encouragingly, we also validate that the signature ARGs are significantly dysregulated in STS, and ARDB2 and SRPK1 are closely connected with the malignant progress of STS cells.ConclusionIn sum, we construct a novel ARSig for STS, which could act as a promising prognostic factor for STS and give a strategy for future clinical decisions, immune landscape, and personalized treatment of STS.
Additional File 6 of Comparative Profiling of Single-Cell Transcriptome Reveals Heterogeneity of Tumor Microenvironment Between Solid and Acinar Lung Adenocarcinoma

Dianke Li,Hua Yu,Junjie Hu,Shaoling Li,Yao Yan,Shuangyi Li,Lishan Sun,Gening Jiang,Likun Hou,Lele Zhang,Peng Zhang

DOI: https://doi.org/10.6084/m9.figshare.21192136

2022-01-01

Abstract:Additional file 6: Table S6. Gene list of signatures for fibroblasts.
Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Qidong Cai,Boxue He,Pengfei Zhang,Zhenyu Zhao,Ping Xiong,Yuqian Zhang,Haiyang Xie,Xiang Wang

DOI: https://doi.org/10.6084/m9.figshare.13346463

2020-01-01

Abstract:Additional file 3: Table S3. Samples for recognizing lymph node metastasis (LNM).
Additional File 2 of A Novel Signature of Two Long Non-Coding RNAs in BRCA Mutant Ovarian Cancer to Predict Prognosis and Efficiency of Chemotherapy

Yinglian Pan,Jia Li,Yuzhu Liu,Yiyu Han,Qian Li,Qin Zou,Zhongpei Zhang,Haiming Jin,Qingchun Deng

DOI: https://doi.org/10.6084/m9.figshare.12980277

2020-01-01

Abstract:Additional file 2: Table S1. Differentially expressed mRNAs and lncRNAs.

Additional File 14 of the Novel Transcriptomic Signature of Angiogenesis Predicts Clinical Outcome, Tumor Microenvironment and Treatment Response for Prostate Adenocarcinoma

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Additional File 3: Table S5. of Differential Expression Analysis at the Individual Level Reveals a Lncrna Prognostic Signature for Lung Adenocarcinoma

Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer

A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma

Additional File 4 of Multi-omics Analysis of Tumor Angiogenesis Characteristics and Potential Epigenetic Regulation Mechanisms in Renal Clear Cell Carcinoma

Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients

Additional File 1 of Identification of a Tumor Microenvironment-Related Seven-Gene Signature for Predicting Prognosis in Bladder Cancer

Additional File 5 of A Novel Signature of Two Long Non-Coding RNAs in BRCA Mutant Ovarian Cancer to Predict Prognosis and Efficiency of Chemotherapy

Bioinformatics Evaluation of a Novel Angiogenesis Related Genes-Based Signature for Predicting Prognosis and Therapeutic Efficacy in Patients with Gastric Cancer.

Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma

Supplementary Figure 6 from Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Additional File 1 of Wnt Pathway-Related Three-Mrna Clinical Outcome Signature in Bladder Urothelial Carcinoma: Computational Biology and Experimental Analyses

Analysis of Angiogenesis-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Lung Adenocarcinoma.

Identification of angiogenesis‐related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer

Integrative Profiling Analysis Reveals Prognostic Significance, Molecular Characteristics, and Tumor Immunity of Angiogenesis-Related Genes in Soft Tissue Sarcoma

Additional File 6 of Comparative Profiling of Single-Cell Transcriptome Reveals Heterogeneity of Tumor Microenvironment Between Solid and Acinar Lung Adenocarcinoma

Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Additional File 2 of A Novel Signature of Two Long Non-Coding RNAs in BRCA Mutant Ovarian Cancer to Predict Prognosis and Efficiency of Chemotherapy